MORGANTI, STEFANIA

MORGANTI, STEFANIA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 42 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
PARP Inhibitors for Breast Cancer Treatment 2024 Morganti StefaniaMarra AntonioGiugliano FedericaBerton Giachetti Pier Paolo MariaCurigliano GiuseppeCriscitiello Carmen + Article (author) -
Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials 2024 Giugliano, FedericaUliano, JacopoMorganti, StefaniaFerraro, EmanuelaTrapani, DarioZagami, PaolaBoldrini, LauraCarnevale Schianca, AmbraCriscitiello, CarmenMarra, AntonioCurigliano, Giuseppe + Article (author) -
Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021 2024 Curigliano, GiuseppeCriscitiello, CarmenMorganti, StefaniaCorti, ChiaraMiller, Robert + Article (author) -
I diritti dei morenti in diversi setting di cura al tempo del Covid-19. Uno studio retrospettivo trasversale sulle opinioni degli operatori sanitari. 2023 Borsellino PGallucci MMorganti SPiga AClerici CASalardi S + Article (author) -
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study 2023 Morganti, StefaniaMarra, AntonioAscione, LilianaVenetis, KonstantinosSajjadi, ElhamZagami, PaolaGiugliano, FedericaBerton Giachetti, Pier Paolo MariaDe Camilli, ElisaCurigliano, GiuseppeFusco, NicolaCriscitiello, Carmen + Article (author) -
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 2023 Sartori G.Vianello A.Nobili A.Mannucci P. M.Violi F.Franchi C.Ardoino I.Barbagallo M.Serafini G.Cappellini M. D.Fabio G.Scaramellini N.Di Stefano V.Leoni S.Di Mauro A. D.Maira D.Clerici M.Di Mauro A. D.Fabrizi M.Martelengo M.Lenti M. V.Pisati M.Cattaneo F.Manzoni F.Gallo P.Corsi M.Brucato A.Squintani G. L.Cerruti L.Di Meo I.Schiavone S.Amoruso E.Fracanzani A. L.Tiraboschi S.Cespiati A.Oberti G.Sigon G.Cinque F.Peyvandi F.Agosti P.Pagliaro E.Semproni E.Monzani V.Savojardo V.Pallini G.Kassem S.Castiglioni L.Bertolotti M.Orlandi L.Battaglia R.Maio R.Ruggeri E.Damiani G.Filippini E.Ghio R.Moreo G.Morganti S.Montalto G.Rizzo A.Catalano A.Caruso R.Quadri R.Vannini G.Harari S.Napoli F.Cattaneo M.Fracasso P.Damanti S. + Article (author) -
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 2022 Tarantino, PaoloAntonarelli, GabrieleBoscolo Bielo, LucaMarra, AntonioCrimini, EdoardoGiugliano, FedericaZagami, PaolaCorti, ChiaraTrapani, DarioMorganti, StefaniaCriscitiello, CarmenCurigliano, Giuseppe + Article (author) -
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation? 2022 Morganti S.Crimini E.Zagami P.Curigliano G. + Article (author) -
Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls 2022 Morganti S.Ferraro E.Ascione L.Vivanet G.Curigliano G.Fusco N.Criscitiello C. + Article (author) -
Tumor-infiltrating lymphocytes (TILs) in paired samples from patients with phenotypic switch from early luminal-like to metastatic triple-negative breast cancer 2022 Morganti, SMarra, AVenetis, KSajjadi, EAscione, LCorti, CZagami, PZattoni, LCurigliano, GFusco, NCriscitiello, C + Article (author) -
How I treat HER2-positive early breast cancer: how long adjuvant trastuzumab is needed? 2022 Morganti, S.Bianchini, G.Curigliano, G.Criscitiello, C. + Article (author) -
Management of Patients with Cardiac Toxicity: The Point of View of the Oncologist 2022 Paola ZagamiStefania MorgantiGiuseppe Curigliano + Book Part (author) -
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials 2022 Venetis K.Morganti S.Sajjadi E.Curci C.Criscitiello C.Fusco N. + Article (author) -
Clinical development and current role of margetuximab for the treatment of breast cancer 2021 Uliano J.Morganti S.Giugliano F.Crimini E.Curigliano G. + Article (author) -
Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trials 2021 Criscitiello, CarmenMarra, AntonioMorganti, StefaniaZagami, PaolaCurigliano, Giuseppe + Article (author) -
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis 2021 Morganti S.Zagami P.Buccimazza G.Venetis K.Mazzarella L.Viale G.Fusco N.Criscitiello C.Curigliano G. + Article (author) -
Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions 2021 Repetto M.Crimini E.Giugliano F.Morganti S.Curigliano G. + Article (author) -
Characterization of low HER2 expressions in de-novo metastatic breast cancer 2021 Tarantino, PZagami, PGiugliano, FCrimini, ECorti, CUliano, JMorganti, SCriscitiello, CCurigliano, G + Article (author) -
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management 2021 Konstantinos VenetisRoberto PiciottiElham SajjadiStefania MorgantiCarmen CriscitielloNicola Fusco + Article (author) -
Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2 2021 Zagami P.Gandini S.Venturini S.Morganti S.Orecchia R.Curigliano G. + Article (author) -